Mexico In-Vitro Diagnostics Market is predicted to reach USD 5.12 Billion by 2030

According to the study by Next Move Strategy Consulting, the Mexico In-Vitro Diagnostics Market size is predicted to reach USD 5.12 billion, at a CAGR of 4.3% by 2030.

Request a FREE Sample: https://www.nextmsc.com/mexico-in-vitro-diagnostics-market/request-sample

The in-vitro diagnostics market in the country is rising rapidly due to significant healthcare expenditure.

The in-vitro diagnostics market growth in Mexico is expected to be driven by the rising incidence of cardiovascular diseases during the forecast period.

The promising players operating in the Mexico in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.